{
    "organizations": [],
    "uuid": "6842c91129bfa9c955c2cba2ea1fcbfa40c76dfe",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gtx-updates-phase-2-enobosarm-clin/brief-gtx-updates-phase-2-enobosarm-clinical-trial-results-idUSASC0A2YA",
    "ord_in_thread": 0,
    "title": "BRIEF-GTx Updates Phase 2 Enobosarm Clinical Trial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - GTX Inc:\n* GTX UPDATES PHASE 2 ENOBOSARM CLINICAL TRIAL RESULTS IN STRESS URINARY INCONTINENCE AT 2018 AUA ANNUAL MEETING\n* GTX INC - TOP-LINE RESULTS FROM ASTRID, AN ONGOING PHASE 2 PLACEBO-CONTROLLED CLINICAL TRIAL, ARE EXPECTED EARLY IN Q4 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-19T02:02:00.000+03:00",
    "crawled": "2018-05-19T15:35:51.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "gtx",
        "inc",
        "gtx",
        "update",
        "phase",
        "enobosarm",
        "clinical",
        "trial",
        "result",
        "stress",
        "urinary",
        "incontinence",
        "aua",
        "annual",
        "meeting",
        "gtx",
        "inc",
        "result",
        "astrid",
        "ongoing",
        "phase",
        "clinical",
        "trial",
        "expected",
        "early",
        "q4",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}